Pharmacokintics of domestic levofloxacin mesylate in healthy volunteers after oral administration of various dose

ZHNG Gui-jun;LI Ke-xin;LIU Lei;HE Gung-wei;SONG You-hu;SUN Chun-hu

Chinese Pharmaceutical Journal ›› 2000, Vol. 35 ›› Issue (06) : 394-396.

Chinese Pharmaceutical Journal ›› 2000, Vol. 35 ›› Issue (06) : 394-396.
临床药学

Pharmacokintics of domestic levofloxacin mesylate in healthy volunteers after oral administration of various dose

  • ZHANG Gui-jun,LI Ke-xin,LIU Lei,HE Guang-wei,SONG You-hua,SUN Chun-hua
Author information +
History +

Abstract

OBJECTIVE To study pharmacokintics of domestic levofloxacin mesylate in healthy volunteers after oral administration of various dose. METHODS Thirty healthy volunteers were divided into 3 grops and given single oral dose of levofloxacin mesylate 100,200,300 mg.The levofloxacin concentrations in serum and urine were determined by HPLC methods.The 3P87(pharmacokinetics program) was used for analysis of metabolism process and parameters of kinetics. RESULTS It ws found that the serum concentrations-time curves were fitted to a two-compartment model.The main pharmacokinetic parameters were as following:tpeak(1.287±0.385) h,(1.121±0.316) h,(1.386±0.233) h;t1/2β(7.669±1.697) h,(6.596±1.207) h,(6.187±0.972) h;and AUC(11.418±1.834) mg·h·L-1,(21.502±4.805) mg·h·L-1,and (32.764±3.564) mg·h·L-1,respectively.There was no significant difference of main pharmacokinetic parameters among three dose groups. CONCLUSION The disposition of levofloxacin mesylate in healthy volunteers was dose-independent.This study will provide a scientific basis for the clinical applications.

Key words

levofloxacin mesylate / HPLC / concentration / pharmacokinetics

Cite this article

Download Citations
ZHNG Gui-jun;LI Ke-xin;LIU Lei;HE Gung-wei;SONG You-hu;SUN Chun-hu. Pharmacokintics of domestic levofloxacin mesylate in healthy volunteers after oral administration of various dose[J]. Chinese Pharmaceutical Journal, 2000, 35(06): 394-396

References

[1]张永信.DR-3355的体外与体内抗菌作用[J].国外医药·抗生素分册,1992,13(1):53. [2]Akiniro Saito,Ken-ichi Oguchi,Yoshimasa Harada,et al.Phar-macokinetics of levofloxacin in patients with impaired renal func-tion[J].Chemotherapy,1992,40(Suppl 3):188. [3]Tanaka K,Iwamoto M,Maesaki S,et al.Laboratory and clinical studies on levofloxacin[J].Jpn J Antibiot,1992,45(5):548. [4]单爱莲,吕媛,李家泰.左旋氧氟沙星和氧氟沙星的临床应用进展与评价[J].中国临床药理学杂志,1997,13(2):115. [5]Goodwin SD,Gallis HA.Pharmacokinetics and safety of levoflox-cin in patients with human immunodeficiency virus infection[J].Antimicrob Agents Chemother,1994,38(4):799.

30

Accesses

0

Citation

Detail

Sections
Recommended

/